Phoenix Biotech Acquisition Corp. (PBAX)
NASDAQ: PBAX
· Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 8:56 PM
Phoenix Biotech Acquisition Revenue
Phoenix Biotech Acquisition reported an annual revenue of $254.83K, reflecting a 0% growth. For the quarter ending September 30, 2023, Phoenix Biotech Acquisition generated $0 in revenue.
Revenue (ttm)
$254.83K
Revenue Growth
0%
Price / Sales Ratio
721.25
Revenue / Employee
-
Employees
undefined
Market Cap
36.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2022 | 254.83K | +Infinity% |
Dec 31, 2021 | 0 | n/a |